Chemed Debt/Equity Ratio 2010-2024 | CHE

Chemed debt/equity ratio for the quarter ending June 30, 2024 was 0.

  • Chemed average debt/equity ratio for 2023 was 0.01, a 93.33% decline from 2022.
  • Chemed average debt/equity ratio for 2022 was 0.15, a 87.5% decline from 2021.
  • Chemed average debt/equity ratio for 2021 was 0.08, a 33.33% increase from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Chemed Debt/Equity Ratio 2010-2024 | CHE

  • Chemed average debt/equity ratio for 2023 was 0.01, a 93.33% decline from 2022.
  • Chemed average debt/equity ratio for 2022 was 0.15, a 87.5% decline from 2021.
  • Chemed average debt/equity ratio for 2021 was 0.08, a 33.33% increase from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.4B
Quest Diagnostics (DGX)$17.3B
DaVita (DVA)$13.8B
Encompass Health (EHC)$9.2B
Elanco Animal Health (ELAN)$7.1B
Option Care Health (OPCH)$5.3B
RadNet (RDNT)$4.9B
Amedisys (AMED)$3.2B
Astrana Health (ASTH)$2.7B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$2.4B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$1B
Aveanna Healthcare Holdings (AVAH)$1B
Atai Life Sciences (ATAI)$215M
Daxor (DXR)$46M
ATI Physical Therapy (ATIP)$26M
MEDIROM Healthcare Technologies (MRM)$19M
Psychemedics (PMD)$14M
Ontrak (OTRK)$10M
Novo Integrated Sciences (NVOS)$5M
IMAC Holdings (BACK)$2M